Genotype and phenotypic expression of hereditary hemochromatosis in Spain;Genotipo y expresión fenotípica de la hemocromatosis hereditaria en España

Gastroenterologia y Hepatologia

Volumn 27, Issue 8, 2004, Pages 437-443

  Pardo, A ^a   Quintero, E ^a   Barrios, Y ^a   Bruguera, M ^b   Rodrigo, L ^c   Vila, C ^d   Acero, D ^e   Guarner, C ^f   Pascual, S ^g   Lopez L ^h   Moreno, R ⁱ   Fabrega E ^j   Andrade, R ^k   Pelaez G ^l   Santos, J ^m   Buti, M ⁿ   Torres, M ^o  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e HOSPITAL JOSEP TRUETA   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^h Hospital Universitario San Agustín   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^j HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^k UNIVERSIDAD DE MÁLAGA   (Spain)

^l Torre Cárdena Hospital   (Spain)

^m HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁿ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^o HOSPITAL DE L ESPERIT SANT   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IRON; TRANSFERRIN;

ADULT; ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; EUROPE; FEMALE; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEMOCHROMATOSIS; HETEROZYGOSITY; HFE GENE; HOMOZYGOSITY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; SPAIN; TRANSFERRIN BLOOD LEVEL;

EID: 6344282570     PISSN: 02105705     EISSN: None     Source Type: Journal    
DOI: 10.1157/13065947     Document Type: Article

References (47)

1. Harrison SA, Bacon BR. Hereditary hemochromatosis: update for 2003. J Hepatol 2003;38:S14-S23.
2. Niederau C, Fischer R, Purschel A, Stremmel W, Haussingr D. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;92:208-12.
3. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996;13:399-408.
4. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996;22:187-94.
5. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114:319-23.
6. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, et al. Hemochromatosis and HLA-H. Nat Genet 1996;14:249-51.
7. Robson KJ, Worwood M, Shearman JD. A simple genetic test identifies 90% of UK patients with hemochromatosis. The UK Hemochromatosis Consortium. Gut 1997;41:841-4.
8. Datz C, Lalloz MRA, Vogel W, Graziadei T, Hackl F, Vautier G, et al. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic hemochromatosis. J Hepatol 1997;27:773-9.
9. Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, De Sousa M, et al. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 1998;243:203-8.
10. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynik JK. A population based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122:646-51.
11. Carella M, D'Ambrosio L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemocromatosis patients. Am J Hum Genet 1997;60:828-32.
12. Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology 1998;114:996-1002.
13. Borot N, Roth M, Malfroy L, Demangel C, Vinel J, Pascal J, et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997;5:371-5.
14. Papanikolaou G, Politou M, Terpos E, Fourlemadis S, Sakellaropoulos N, Loukopoulos D, et al. Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity. Blood Cells Mol Dis 2000;26:163-8.
15. Sánchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R, et al. Prevalence of the Cys282Tyr and His63Asp gene mutations in Spanish patients with hereditary hemocromatosis and in controls. J Hepatol 1998;29:725-8.
16. Sánchez M, Bruguera M, Quintero E, Barrio Y, Mazzara R, Rodes J, et al. Hereditary hemochromatosis in Spain. Genet Test 2000;4:171-6.
17. Guix P, Picornell A, Parera M, Tomas C, Muncunill J, Castro JA, et al. Prevalence of the C282Y mutation for haemochromatosis on the Island of Majorca. Clin Genet 2000;58:123-8.
18. Fabrega E, Castro B, Sánchez-Castro L, Benito A, Fernández-Luna JL, Pons-Romero F. Prevalencia de la mutación Cys282Tyr del gen de la hemocromatosis en pacientes diagnosticados de hemocromatosis hereditaria de Cantabria. Med Clin (Barc) 1999;112:451-3.
19. De Juan D, Reta A, Castiella A, Pozueta J, Prada A, Cuadrado E. HFE gene mutations analysis in Basque hereditary haemochromatosis patients and controls. Eur J Hum Genet 2001;9:961-4.
20. Jorquera F, Domínguez A, Díaz-Golpe V, Espinel J, Muñoz F, Herrera A, et al. Mutaciones C282Y y H63D del gen de la hemocromatosis en pacientes con sobrecarga férrica. Rev Esp Enf Dig 2001;93:293-302.
21. EASL International Consensus Conference on Hemochromatosis. J Hepatol 2000;33:485-504.
22. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population based study of the clinical expression of the hemocromatosis gene. N Engl J Med 1999;341:718-24.
23. Asberg A, Hveem K, Thorstensen K, Ellekjeter E, Kannelonning K, Fjosne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
24. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G → A (C282Y) HFE hereditary hemochromatosis mutation in the USA. Lancet 2002;359:211-8.
25. Cotler SJ, Bronner MP, Press RD, Carlson TH, Perkins JD, Emond MJ, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998;29:257-62.
26. Shaheen NJ, Bacon BR, Grimm IS. Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation. Hepatology 1998;28:526-9.
27. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36.
28. Piperno A, Arosio C, Fossati L, Vigano M, Trombini P, Vergani A, et al. Two novel nonsense mutations of HFE gene in five unrelated italian patients with hemochromatosis. Gastroenterology 2000;119:441-5.
29. Camaschella C, Roetto A, Cali A, DeGobbi M, Garozzo G, Carella M, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-5.
30. Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97:2555-60.
31. Girelli D, Bozzini C, Roetto A, Alberti F, Daraio F, Colombari R, et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene. Gastreonterology 2002;122:1295-302.
32. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-23.
33. Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT. Two novel missense mutations of the HFE gene (1105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis 1999;25:147-55.
34. Aguilar-Martínez P, Esculie-Coste C, Bismuth M, Giansily-Blaizot M, Larrey D, Schved JF. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Blood Cells Mol Dis 2001;27:290-3.
35. Wallace DF, Pedersen P, Dixon JL, Stephenson P, Searle JW, Powell LW, et al. Novel mutation in ferroportin I is associated with autosomal dominant hemochromatosis. Blood 2002;100:692-4.
36. Devalia V, Carter K, Walker AP, Perkins SJ, Worwood M, May A, et al. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 2002;100:695-7.
37. Lee PL, Halloran C, West C, Beutler E. Mutation analysis of the transferring receptor-2 gene in patients with iron overload. Blood Cells Mol Dis 2001;72:85-9.
38. Cassanelli S, Pignatti E, Montosi G, Garuti C, Mariano M, Campioli D, et al. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol 2001;34:523-8.
39. Guix P, Picornell A, Parera M, Galmes A, Obrador A, Ramon MM, et al. Distribution of HFE C282Y and H63D mutations in the Balearic Islands (NE Spain). Clin Genet 2002;61:43-8.
40. Álvarez S, Mesa MS, Bandres F, Arroyo E. C282Y and H63D mutation frequencies in a population from central Spain. Dis Markers 2001;17:111-4.
41. Lucotte G. Frequency analysis and allele map in favor of the celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis 2001;27:549-56.
42. Piazza A, Rendine S, Minch E, Menozzi P, Mountain J, Cavalli-Sforza L. Genetics and the origin of European languages. Proc Natl Acad Sci U S A 1995;92:5836-40.
43. Quintana-Murci L, Veitia R, Fellous M, Semino O, Poloni ES. Genetic structure of Mediterranean populations revealed by Y-chromosome haplotype analysis. Am J Phys Anthropol 2003;121:157-71.
44. Scozzari R, Cruciani F, Pangrazio A, Santolamazza P, Vona G, Moral P, et al. Human Y-chromosome variation in the western Mediterranean area: implications for the peopling of the region. Hum Immunol 2001;62:871-84.
45. Barton JC, Barton NH, Alford TJ. Diagnosis of hemochromatosis probands in a community hospital. Am J Med 1997;103:498-503.
46. Bacon BR, Sadiq S. Hereditary hemochromatosis: diagnosis in the 1990's. Am J Gastroenterol 1997;92:784-9.
47. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997;127:105-10.